Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition

McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide L. Michael Posey, RPh, is president of Pharmacy Editorial & News Services (PENS) in Athens, Georgia, and an editor for the APhA periodicals Journal of the American Pharmacists Association, Pharmacy Today, and APhA DrugInfoLine. He also assists with drug information content for APhAs cutting-edge Web site, www.pharmacist.com. During a career spanning two decades as a pharmacy communicator, Posey has served as editor of The Consultant Pharmacist and the American Journal of Hospital Pharmacy, and is an editor of the textbook Pharmacotherapy: A Pathophysiologic Approach.

Section 1: Foundation IssuesSection Editor: L. Michael Posey

1.Pharmacoeconomics: Principles, Methods, and Applications

2.Health Outcomes and Quality of Life

3.Health Literacy and Medication Use

4.Cultural Competency

5.Principles and Practices of Medication Safety

6.Evidence Based Medicine

7.Documentation of Pharmacy Services

8.Clinical Pharmacokinetics and Pharmacodynamics

9.Pharmacogenetics

10.Pediatrics

11.Geriatrics

12.Palliative Care

13. Pharmacoepidemiology

14. Clinical Toxicology

15. Emergency Preparedness: Identification and Management of Biologic Exposures

16. Emergency Preparedness: Identification adn Management of Chemical and Radiologic Exposures

Section 2: Cardiovascular DisordersSection Editor: Robert L. Talbert

17.Cardiovascular Testing

18.Cardiac Arrest

19.Hypertension

20.Systolic Heart Failure

21.Diastolic Heart Failure and the Cardiomyopathies

22.Acute Decompensated Heart

23.Ischemic Heart DiseaseJ

24.Acute Coronary Syndromes

25.The Arrhythmias

26. Venous Thromboembolism

27.Stroke

28.Dyslipidemia

29.Peripheral Arterial Disease

30.Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock

31.Hypovolemic Shock

Section 3: Respiratory DisordersSection Editor: Robert L. Talbert

32.Introduction to Pulmonary Function Testing

33.Asthma

34.Chronic Obstructive Pulmonary Disease

35.Pulmonary Hypertension

36.Drug-Induced Pulmonary Diseases

37.Cystic Fibrosis

Section 4: Gastrointestinal DisordersSection Editor: Joseph T. DiPiro

38.Evaluation of the Gastrointestinal Tract

39.Gastroesophageal Reflux Disease

40.Peptic Ulcer Disease

41.Inflammatory Bowel Disease

42.Nausea and Vomiting

43.Diarrhea, Constipation, and Irritable Bowel Syndrome

44.Portal Hypertension and Cirrhosis

45.Drug-Induced Liver Disease

46.Pancreatitis

47.Viral Hepatitis

48.Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity

49. Celiac Disease

Section 5: Renal DisordersSection Editor: Gary R. Matzke

50.Clinical Assessment of Kidney Function

51.Acute Kidney Injury

52.Chronic Kidney Disease: Progression-Modifying Therapies

53.Chronic Kidney Disease: Management of Complications

54.Hemodialysis and Peritoneal Dialysis

55.Drug-Induced Kidney Disease

56.Glomerulonephritis

57.Drug Therapy Individualization for Patients with Renal Insufficiency

58.Disorders of Sodium and Water Homeostasis

59.Disorders of Calcium and Phosphorus Homeostasis

60.Disorders of Potassium and Magnesium HomeostasisDonald F. Brophy and Todd W. B. Gehr

61.Acid-Base Disorders

Section 6: Neurologic DisordersSection Editor: Barbara G. Wells

62.Evaluation of Neurologic Illness

63.Alheimer's Disease

64. Multiple Sclerosis

65. Epilepsy

66.Status Epilepticus

67.Acute Management of the Brain Injury Patient

68.Parkinson's Disease

69. Pain Management

70.Headache Disorders

Section 7: Psychiatric DisordersSection Editor: Barbara G. Wells

71.Evaluation of Psychiatric Illness

72.Childhood Disorders

73.Eating Disorders

74.Substance Related Disroders: Overview and Depressahts, Stimulants and Hallucinogens

75.Substance-Related Disorders: Alcohol, Nicotine, and Caffeine

76.Schizophrenia

77.Major Depressive Disorders

78.Bipolar Disorder

79.Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders

80.Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder

81.Sleep Disorders

82.Disorders Associated with Intellectual Disabilities83.Diabetes Mellitus

84.Thyroid Disorders

85.Adrenal Gland Disorders

86.Pituitary Gland Disorders

Section 9: Gynecologic and Obstetric DisordersSection Editor: Barbara G. Wells

87.Pregnancy and Lactation: Therapeutic Considerations

88.Contraception

89.Menstruation-Related Disorders

90.Endometriosis

91. Hormone Terapy in Women

Section 10: Urologic DisordersSection Editor: L. Michael Posey

92.Erectile Dysfunction

93.Benign Prostatic Hyperplasia

94.Urinary Incontinence

Section 11: Immunologic DisordersSection Editor: Gary C. Yee

95. Function and Evaluation of the Immune System

96.Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases

97.Allergic and Pseudoallergic Drug Reactions

98.Solid-Organ Transplantation

Section 12: Rheumatologic DisordersSection Editor: L. Michael Posey

99Osteoporosis and Other Metabolic Bone Diseases

100.Rheumatoid Arthritis

101.Osteoarthritis

102. Gout and Hyperuricemia

Section 13: Ophthalmic and Otolaryngological DisordersSection Editor: L. Michael Posey

103.Glaucoma

104.Allergic Rhinitis

Section 14: Dermatologic DisordersSection Editor: L. Michael Posey

105Dermatologic Drug Reactions and Common Skin Conditions

106.Acne Vulgaris

107.Psoriasis

108.Atopic Dermatitis

Section 15: Hematologic DisordersSection Editor: Gary C. Yee

109.Anemias

110.Coagulation Disorders

111. Sickle Cell Disease

112.Drug-Induced Hematologic Disorders

Section 16: Infectious DiseasesSection Editor: Joseph T. DiPiro

113.Laboratory Tests to Direct Antimicrobial Pharmacotherapy

114.Antimicrobial Regimen Selection

115.Central Nervous System Infections

116.Lower Respiratory Tract Infections

117.Upper Respiratory Tract Infections

118.Influenza

119.Skin and Soft Tissue Infections

120.Infective Endocarditis

121.Tuberculosis

122.Gastrointestinal Infections and Enterotoxigenic Poisonings

123.Intraabdominal Infections

124.Parasitic Diseases

125.Urinary Tract Infections and Prostatitis

126.Sexually Transmitted Diseases

127.Bone and Joint Infections

128.Sepsis and Septic Shock

129.Superficial Fungal Infections

130.Invasive Fungal Infections

131.Infections in Immunocompromised Patients

132.Antimicrobial Prophylaxis in Surgery

133.Vaccines, Toxoids, and Other Immunobiologics

134.Human Immunodeficiency Virus Infection

Section 17: Oncologic DisordersSection Editor: Gary C. Yee

135.Cancer Treatment and Chemotherapy

136.Breast Cancer

137.Lung Cancer

138.Colorectal Cancer

139.Prostate Cancer

140.Lymphomas

141.Ovarian Cancer

142.Acute Leukemias

143.Chronic Leukemias

144.Multiple Myeloma

145.Myelodysplastic Syndromes (Web-only)

146.Skin Cancer

147. Melanoma

148. Hematopoietic Stem Cell Transplantation

Section 18: Nutritional DisordersSection Editor: Gary R. Matzke

149.Assessment of Nutrition Status and Nutrition Requirements

150.Medication Administration Considerations With Specialized Nutrition Support

151.Parenteral Nutrition

152.Enteral Nutrition

153.Nutritional Considerations in Major Organ Failure

154.Obesity

Glossary

Index